Prophylactic citalopram treatment in hepatitis C patients on antiviral therapy: Will it limit drug-induced depression and enhance adherence?

Current Psychiatry Reports

Volumn 13, Issue 1, 2011, Pages 1-2

  Wise, Thomas N ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; PEGINTERFERON ALPHA; PLACEBO; RIBAVIRIN;

ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FOLLOW UP; GENOTYPE; HAMILTON ANXIETY SCALE; HEPATITIS C; HUMAN; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROTOXICITY; PATIENT COMPLIANCE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

EID: 79551532365     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-010-0161-3     Document Type: Article

References (3)

1. DL Musselman DH Lawson JF Gumnick, et al. 2001 Paroxetine for the prevention of depression induced by high dose interferon alpha N Engl J Med 344 961 966 1:CAS:528:DC%2BD3MXislyktrc%3D 10.1056/NEJM200103293441303 11274622 (Pubitemid 32240314)
2. M Schaefer M Schwaiger AS Garkisch, et al. 2005 Prevention of interferon-alpha associated depression in psychiatric risk patients with hepatitis C J Hepatol 42 793 798 1:CAS:528:DC%2BD2MXktVGmtrg%3D 10.1016/j.jhep.2005.01.020 15885349 (Pubitemid 40693194)
3. BJ Morasco MA Rifai JM Loftis, et al. 2007 A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C J Affect Disord 103 83 90 1:CAS:528:DC%2BD2sXhtFSltr7J 10.1016/j.jad.2007.01.007 17292481 (Pubitemid 47445756)